Acuta Capital Partners’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
GS
HCMT
PAPAIJV
TGHSA
GA
RA
OTPPB
BCM
Acuta Capital Partners's CDNA Position: Q3 2016 in Review
Acuta Capital Partners sold out of CareDx (CDNA) in Q3 2016, closing a stake of 64,627 shares — an estimated $279K sold.
Acuta Capital Partners first reported a position in CDNA in Q2 2016 and held it in 1 quarter. The position peaked at $279K in Q2 2016. 25 funds tracked by Wall St. Rank hold CDNA as of Q3 2016.
- Acuta Capital Partners reported no remaining CareDx position as of Q3 2016 after selling out during the quarter.
- Acuta Capital Partners sold 64,627 CareDx shares in Q3 2016, an estimated $279K.
- Acuta Capital Partners first reported a position in CareDx in Q2 2016 and held it in 1 quarter.
- Acuta Capital Partners's CareDx position peaked at $279K in Q2 2016.
- 25 funds tracked by Wall St. Rank held CareDx as of Q3 2016.
Based on Acuta Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.